SWOG clinical trial number
SWOG-8997 (EST-3887) (ECOG-3887)

Chemotherapy of Disseminated Advanced Stage Testicular Cancer with Cisplatin Plus Etoposide with Either Bleomycin or Ifosfamide

Closed
Phase
Published
Abbreviated Title
Chemotherapy of Disseminated Advanced Stage Testicular Cancer with Cisplatin Plus Etoposide with Either Bleomycin or Ifosfamide
Activated
10/01/1989
Closed
04/09/1992

Publication Information Expand/Collapse

2009

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

Minority report: how best to analyze clinical trial data to address disparities

D Hershman;J Unger Breast Cancer Research and Treatment 118:519-521

1998

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study.

CR Nichols;PJ Catalano;ED Crawford;NJ Vogelzang;LH Einhorn;PJ Loehrer Journal of Clinical Oncology 16(4):1287-1293

1993

Phase III study of cisplatin (P) plus etoposide (VP16) with either bleomycin (B) or ifosfamide (I) in advanced stage germ cell tumors (GCT): An Intergroup trial

PJ Loehrer;LH Einhorn;P Elson;SD Williams;K Havlin;NJ Vogelzang;ED Crawford;DL Trump ASCO 12:261(#831)